Aspiration of Subglottic Secretions Using Hi-Lo Evac Endotracheal Tube: Tube Size and Incidence of Suction Lumen Dysfunction

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2007 by University Hospital, Alexandroupolis.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
University Hospital, Alexandroupolis
ClinicalTrials.gov Identifier:
NCT00450476
First received: March 21, 2007
Last updated: NA
Last verified: March 2007
History: No changes posted
  Purpose

To evaluate the correlation between endotracheal tube size and incidence of dysfunction of suction lumen of Hi-Lo Evac endotracheal tube in critically ill patients who required mechanical ventilation for more than 48 hours.


Condition Intervention Phase
Aspiration of Subglottic Secretions
Device: Hi-Lo Evac Endotracheal Tube
Phase 4

Study Type: Observational
Study Design: Allocation: Random Sample
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Official Title: Aspiration of Subglottic Secretions in Intubated Critically Ill Patients Using Hi-Lo Evac Endotracheal Tube: Correlation Between Tube Size and Incidence of Suction Lumen Dysfunction

Further study details as provided by University Hospital, Alexandroupolis:

Estimated Enrollment: 60
Study Start Date: January 2007
Detailed Description:

In mechanically ventilated patients, aspiration of subglottic secretions is a widely used intervention for prevention of ventilator-associated pneumonia. Using Hi–Lo® Evac endotracheal tube (Hi-Lo Evac; Mallinckrodt; Athlone, Ireland), dysfunction of suction lumen and subsequent failure to aspirate the subglottic secretions is not uncommon. The objective of this prospective observational study is to determine the causes and the incidence of suction lumen dysfunction of Evac endotracheal tube.

  Eligibility

Ages Eligible for Study:   18 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Critically ill patients with orotracheal intubation and anticipated duration of intubation more than 48 hours
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00450476

Contacts
Contact: Christos K Dragoumanis, MD, PhD 00302551075085 christosdragoumanis@gmail.com

Locations
Greece
University General Hospital of Alexandroupolis Recruiting
Alexandroupolis, Evros, Greece, 68100
Principal Investigator: Christos K Dragoumanis, MD, PhD         
Sub-Investigator: Vassilios Papaiannou, MD, PhD         
Sub-Investigator: Dimitrios Konstantonis, MD, PhD         
Sponsors and Collaborators
University Hospital, Alexandroupolis
Investigators
Principal Investigator: Christos K Dragoumanis, MD, PhD Intensive Care Unit, University Hospital of Alexandroupolis
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00450476     History of Changes
Other Study ID Numbers: 30/3/25-01-2007
Study First Received: March 21, 2007
Last Updated: March 21, 2007
Health Authority: Greece: Ethics Committee

Keywords provided by University Hospital, Alexandroupolis:
ventilator associated pneumonia
prevention
endotracheal intubation
mechanical ventilation

ClinicalTrials.gov processed this record on July 29, 2014